106 related articles for article (PubMed ID: 3082559)
1. Clinical pharmacokinetics of oral and injectable gold compounds.
Blocka KL; Paulus HE; Furst DE
Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
[TBL] [Abstract][Full Text] [Related]
2. The Molecule of the Week: A Didactic Tool for Teaching General Chemistry.
Togni A
Chimia (Aarau); 2020 Aug; 74(7-8):615-617. PubMed ID: 32778215
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of auranofin in animals.
Intoccia AP; Flanagan TL; Walz DT; Gutzait L; Swagzdis JE; Flagiello J; Hwang BY; Dewey RH; Noguchi H
J Rheumatol Suppl; 1982; 8():90-8. PubMed ID: 6813497
[TBL] [Abstract][Full Text] [Related]
4. Gold kinetics under long-term treatment with gold(I) disodium thiomalate: a comparison in three different mouse strains.
Tonn T; Goebel C; Wilhelm M; Gleichmann E
Br J Rheumatol; 1994 Aug; 33(8):724-30. PubMed ID: 8055198
[TBL] [Abstract][Full Text] [Related]
5. Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer.
DeAngelo SL; Dziechciarz S; Solanki S; Shin M; Zhao L; Balia A; El-Derany MO; Das NK; Castillo C; Bell HN; Paulo JA; Zhang Y; Rossiter NJ; McCulla EC; He J; Talukder I; Schafer ZT; Neamati N; Mancias JD; Koutmos M; Shah YM
bioRxiv; 2024 Apr; ():. PubMed ID: 38617233
[TBL] [Abstract][Full Text] [Related]
6. Prospecting Cellular Gold Nanoparticle Biomineralization as a Viable Alternative to Prefabricated Gold Nanoparticles.
Schwartz-Duval AS; Sokolov KV
Adv Sci (Weinh); 2022 Jul; 9(20):e2105957. PubMed ID: 35508715
[TBL] [Abstract][Full Text] [Related]
7. Will Auranofin Become a Golden New Treatment Against COVID-19?
Sonzogni-Desautels K; Ndao M
Front Immunol; 2021; 12():683694. PubMed ID: 34630379
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome.
Yang G; Lee SJ; Kang HC; Cho YY; Lee HS; Zouboulis CC; Han SH; Ma KH; Jang JK; Lee JY
Biomol Ther (Seoul); 2020 Sep; 28(5):437-442. PubMed ID: 32319265
[TBL] [Abstract][Full Text] [Related]
9. Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor.
Nag D; Bhanja P; Riha R; Sanchez-Guerrero G; Kimler BF; Tsue TT; Lominska C; Saha S
Clin Cancer Res; 2019 Aug; 25(15):4791-4807. PubMed ID: 30940656
[TBL] [Abstract][Full Text] [Related]
10. Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia.
Fidyt K; Pastorczak A; Goral A; Szczygiel K; Fendler W; Muchowicz A; Bartlomiejczyk MA; Madzio J; Cyran J; Graczyk-Jarzynka A; Jansen E; Patkowska E; Lech-Maranda E; Pal D; Blair H; Burdzinska A; Pedzisz P; Glodkowska-Mrowka E; Demkow U; Gawle-Krawczyk K; Matysiak M; Winiarska M; Juszczynski P; Mlynarski W; Heidenreich O; Golab J; Firczuk M
Mol Oncol; 2019 May; 13(5):1180-1195. PubMed ID: 30861284
[TBL] [Abstract][Full Text] [Related]
11. Assessment of bioavailability of gold bhasma in human participants - A pilot study.
Patil-Bhole T; Patil S; Wele AA
J Ayurveda Integr Med; 2018; 9(4):294-297. PubMed ID: 30459077
[TBL] [Abstract][Full Text] [Related]
12. Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci.
AbdelKhalek A; Abutaleb NS; Elmagarmid KA; Seleem MN
Sci Rep; 2018 May; 8(1):8353. PubMed ID: 29844350
[TBL] [Abstract][Full Text] [Related]
13. In vitro antineoplastic effects of auranofin in canine lymphoma cells.
Zhang H; Rose BJ; Pyuen AA; Thamm DH
BMC Cancer; 2018 May; 18(1):522. PubMed ID: 29724201
[TBL] [Abstract][Full Text] [Related]
14. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
[TBL] [Abstract][Full Text] [Related]
15. Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.
Miyamoto Y; Eckmann L
Front Microbiol; 2015; 6():1208. PubMed ID: 26635732
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma.
Kikuchi K; Soundararajan A; Zarzabal LA; Weems CR; Nelon LD; Hampton ST; Michalek JE; Rubin BP; Fields AP; Keller C
Oncogene; 2013 Jan; 32(3):286-95. PubMed ID: 22349825
[TBL] [Abstract][Full Text] [Related]
17. Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells.
Regala RP; Thompson EA; Fields AP
Cancer Res; 2008 Jul; 68(14):5888-95. PubMed ID: 18632643
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration.
Liston TE; Conklyn MJ; Houser J; Wilner KD; Johnson A; Apseloff G; Whitacre C; Showell HJ
Br J Clin Pharmacol; 1998 Feb; 45(2):115-21. PubMed ID: 9491823
[TBL] [Abstract][Full Text] [Related]
19. Adverse reactions with oral and parenteral gold preparations.
Tozman EC; Gottlieb NL
Med Toxicol; 1987; 2(3):177-89. PubMed ID: 3298922
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
